Guangzhou Baiyunshan Pharmaceutical Holdings (00874) reported a net profit attributable to shareholders of approximately RMB2.492 billion for the first three quarters, down 24.73% year on year.
Baiyunshan (00874) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB62.076 billion, up 0.76% year on year; net profit attributable to shareholders of the listed company of approximately RMB2.492 billion, down 24.73% year on year; and basic earnings per share of RMB1.533.
Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB62.076 billion, up 0.76% year on year; net profit attributable to shareholders of the listed company of approximately RMB2.492 billion, down 24.73% year on year; and basic earnings per share of RMB1.533.
Related Articles
HK Bull/Bear Outstanding Qty Ratio(47:53) | October 29
Alphabet (GOOGL.US) Q3 cloud revenue surged 103% year-over-year; free cash flow turned negative from positive; stock plunged over 11% after hours.
Microsoft Corporation (MSFT.US) Q1 revenue grew 19% year-over-year to nearly US$92.3 billion; Azure revenue surged 48%
HK Bull/Bear Outstanding Qty Ratio(47:53) | October 29
Alphabet (GOOGL.US) Q3 cloud revenue surged 103% year-over-year; free cash flow turned negative from positive; stock plunged over 11% after hours.
Microsoft Corporation (MSFT.US) Q1 revenue grew 19% year-over-year to nearly US$92.3 billion; Azure revenue surged 48%
